Epilepsy as a Network Disorder (1): What can we learn from other network disorders such as autistic spectrum disorder and mood disorders?

Epilepsy and Behavior

Volumn 77, Issue , 2017, Pages 106-113

  Kanner, Andres M ^a   Scharfman, Helen ^b,c   Jette, Nathalie ^d,e   Anagnostou, Evdokia ^f   Bernard, Christophe ^g   Camfield, Carol ^h   Camfield, Peter ^h   Legg, Karen ⁱ   Dinstein, Ilan ^j   Giacobbe, Peter ^k   Friedman, Alon ^j,l   Pohlmann Eden, Bernd ^h  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

^f University of Toronto   (Canada)

^g AIX MARSEILLE UNIVERSITÉ   (France)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^j BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^k UNIVERSITY OF TORONTO   (Canada)

^l DALHOUSIE UNIVERSITY   (Canada)

more..

Author keywords

Autistic spectrum disorder; Cortisol; Glutamate; Major depression; Stress

Indexed keywords

NEUROTRANSMITTER;

ALZHEIMER DISEASE; AUTISM; BENIGN CHILDHOOD EPILEPSY; BRAIN DEPTH STIMULATION; CLINICAL RESEARCH; CLINICAL STUDY; COMORBIDITY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; ENDOCRINE DISEASE; EPIDEMIOLOGICAL MONITORING; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; FUNCTIONAL CONNECTIVITY; HUMAN; IMMUNOLOGICAL MONITORING; MOOD DISORDER; NEUROBIOLOGY; NEUROMONITORING; NEUROTRANSMISSION; NONHUMAN; ONSET AGE; PEDIATRICS; PRECLINICAL STUDY; PSYCHOSIS; PUBLICATION; REVIEW; ROOT CAUSE ANALYSIS; SCHIZOPHRENIA; STRESS; TRANSLATIONAL RESEARCH; COMPLICATION; PSYCHOLOGY;

AUTISTIC DISORDER; EPILEPSY; HUMANS; MOOD DISORDERS;

EID: 85032277518     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2017.09.014     Document Type: Review

References (107)

1. Gangadeep, S., Management of medical comorbifity associated with epilepsy. Shorvon, S., Perucca, E., Engel, J. Jr., (eds.) The treatment of epilepsy, 2016, Wiley Blackwell, Oxford UK, 245–254.
2. Kanner, A.M., Management of psychiatric and neurological comorbidities in epilepsy. Nat Rev Neurol 12:2 (2016), 106–116.
3. Kanner, A.M., Barry, J.J., Gilliam, F., Hermann, B., Meador, K.J., Anxiety disorders, sub-syndromic depressive episodes and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?. Epilepsia 51 (2010), 1152–1158.
4. Hesdorffer, D.C., Ishihara, L., Mynepalli, L., Webb, D.J., Weil, J., Hauser, W.A., Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol 72 (2012), 184–191.
5. Jossephson, C.B., Lowerison, M., Vallerand, I., Sajobi, T.T., Patten, S., Jette, N., et al. Association of depression and treated depression with epilepsy and seizure outcomes: a multicohort analysis. JAMA Neurol 74 (2017), 533–539, 10.1001/jamaneurol.2016.5042.
6. Hitiris, N., Mohanraj, R., Norrie, J., et al. Predictors of pharmacoresistant epilepsy. Epilepsy Res 75 (2007), 192–196.
7. Petrovski, S., Szoeke, C.E.I., Jones, N.C., Salzberg, M.R., Sheffield, L.J., Huggins, R.M., et al. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology 75 (2010), 1015–1021.
8. Kanner, A.M., Byrne, R., Chicharro, A., Wuu, J., Frey, M., A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology 72:9 (3 2009), 793–799.
9. Perucca, P., Jacoby, A., Marson, A.G., Baker, G.A., Lane, S., Benn, E.K., et al. Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology 76:3 (18 2011), 273–279.
10. Fazel, S., Wolf, A., Långström, N., Newton, C.R., Lichtenstein, P., Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet 382:9905 (16 2013), 1646–1654.
11. Cramer, J.A., Blum, D., Fanning, K., Reed, M., Epilepsy Impact Project Group, The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 5:3 (2004), 337–342.
12. Volkmar, F.R., McPartland, J.C., From Kanner to DSM-5: autism as an evolving diagnostic concept. Annu Rev Clin Psychol 10 (2014), 193–212.
13. Amiet, C., Gourfinkel-An, I., Bouzamondo, A., Tordjman, S., Baulac, M., Lechat, P., et al. Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biol Psychiatry 64:7 (1 2008), 577–582.
14. Viscidi, E.W., Triche, E.W., Pescosolido, M.F., McLean, R.L., Joseph, R.M., Spence, S.J., et al. Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy. PLoS One, 8(7), 2013, e67797.
15. Fiest, K.M., Dykeman, J., Patten, S.B., Wiebe, S., Kaplan, G.G., Maxwell, C.J., et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology 80:6 (5 2013), 590–599.
16. Hesdorffer, D.C., Comorbidity between neurological illness and psychiatric disorders. CNS Spectr 21:3 (2016), 230–238.
17. Clarke, M.C., Connor, D.J., Cannon, M., Cotter, D.R., The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry, 14, 2014, 75.
18. Horváth, A., Szűcs, A., Barcs, G., Noebels, J.L., Kamondi, A., Epileptic seizures in Alzheimer disease: a review. Alzheimer Dis Assoc Disord 30:2 (2016), 186–192.
19. Lam, A.D., Deck, G., Goldman, A., Eskandar, E.N., Noebels, J., Cole, A.J., Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease. Nat Med 23:6 (2017), 678–680.
20. Berg, A.T., Plioplys, S., Tuchman, R., Risk and correlates of autism spectrum disorder in children with epilepsy: a community-based study. J Child Neurol 26 (2011), 540–557.
21. Frye, R.E., Casanova, M.F., Hossein-Fatemi, S., Folsom, T.D., Reutiman, T.J., Brown, G.L., et al. Neuropathological mechanisms of seizures in autism spectrum disorder. Front Neurosci, 10, 2016, 192 [ www.frontiersin.org].
22. Lee, B.H., Smith, T., Paciorkowski, A.C., Autism spectrum disorder and epilepsy: disorders with a shared biology. Epilepsy Behav 47 (2015), 191–201.
23. Pohlmann-Eden, B., Legg, K., Crocker, C., Definition of new-onset epilepsy versus newly diagnosed epilepsy: role of time domain (letter). Epilepsia 53:7 (2012), 1275–1279.
24. Unauthored, Brain gains. The economist, Jan 30, 2016, 37–74.
25. Tuchman, R., Hirtz, D., Mamounas, L.A., NINDS epilepsy and autism spectrum disorders workshop report. Neurology 81:18 (29 2013), 1630–1636.
26. Stoner, R., Chow, M.L., Boyle, M.P., Sunkin, S.M., Mouton, P.R., Roy, S., et al. Patches of disorganization in the neocortex of children with autism. N Engl J Med 370:13 (27 2014), 1209–1219.
27. Palmer, E.E., Stuhlmann, T., Weinert, S., et al. De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females. Mol Psychiatry 00 (2016), 1–9.
28. Saemundsen, E., Juliusson, H., Hjaltested, S., et al. Prevalence of autism in an urban population of adults with severe intellectual disabilities—a preliminary study. J Intellect Disabil Res 54 (2010), 727–735.
29. Saemundsen, E., Ludvingsson, P., Rafnsson, V., Autism spectrum disorders in children with a history of infantile spasms: a population-based study. J Child Neurol 22 (2007), 1102–1107.
30. Yasuhara, A., Yasuhara, A., Correlation between EEG abnormalities and symptoms of autism spectrum disorder (ASD). Brain Dev 32:10 (2010), 791–798.
31. Sanchez-Fernandez, I., Loddenkemper, T., Galanopoulou, A.S., Moshe, S.L., Should epileptiform discharges be treated?. Epilepsia 56 (2015), 1492–1504 [2015].
32. Rubenstein, J.L.R., Merzenich, M.M., Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2 (2003), 255–267.
33. Sanders, S.J., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70 (2011), 863–885.
34. Chen, C.-H., et al. Genetic analysis of GABRB3 as a candidate gene of autism spectrum disorders. Mol Autism, 5, 2014, 36.
35. Fatemi, S.H., et al. Downregulation of GABAA receptor protein subunits α6, β2, δ, ε, γ2, θ, and ρ2 in superior frontal cortex of subjects with autism. J Autism Dev Disord 44 (2014), 1833–1845.
36. Fatemi, S.H., Reutiman, T.J., Folsom, T.D., Thuras, P.D., GABA(A) receptor downregulation in brains of subjects with autism. J Autism Dev Disord 39 (2009), 223–230.
37. Chao, H.-T., et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468 (2010), 263–269.
38. Yizhar, O., et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477 (2011), 171–178.
39. Robertson, C.E., Ratai, E.-M., Kanwisher, N., Reduced GABAergic action in the autistic brain. Curr Biol 26 (2016), 80–85.
40. Robertson, C.E., Kravitz, D.J., Freyberg, J., Baron-Cohen, S., Baker, C.I., Slower rate of binocular rivalry in autism. J Neurosci 33 (2013), 16983–16991.
41. Simmons, D.R., et al. Vision in autism spectrum disorders. Vision Res 49 (2009), 2705–2739.
42. Dinstein, I., Heeger, D.J., Behrmann, M., Neural variability: friend or foe?. Trends Cogn Sci 19 (2015), 322–328.
43. Churchland, M.M., et al. Stimulus onset quenches neural variability: a widespread cortical phenomenon. Nat Neurosci 13 (2010), 369–378.
44. Arieli, A., Sterkin, A., Grinvald, A., Aertsen, A., Dynamics of ongoing activity: explanation of the large variability in evoked cortical responses. Science (80-. ) 273 (1996), 1868–1871.
45. Vreeswijk, C.V., Sompolinsky, H., Chaos in neuronal networks with balanced excitatory and inhibitory activity. Science (80-. ) 274 (1996), 1724–1726.
46. Markram, H., Rinaldi, T., Markram, K., The intense world syndrome – an alternative hypothesis for autism. Front Neurosci 1:1 (2007), 77–96.
47. Belmonte, M.K., et al. Autism as a disorder of neural information processing: directions for research and targets for therapy. Mol Psychiatry 9 (2004), 646–663.
48. Schurger, A., Sarigiannidis, I., Naccache, L., Sitt, J.D., Dehaene, S., Cortical activity is more stable when sensory stimuli are consciously perceived. Proc Natl Acad Sci U S A 112 (2015), E2083–92.
49. Arazi, A., Censor, N., Dinstein, I., Neural variability quenching predicts individual perceptual abilities. J Neurosci 36 (2016), 1–13.
50. Haigh, S.M., Heeger, D.J., Dinstein, I., Minshew, N., Behrmann, M., Cortical variability in the sensory-evoked response in autism. J Autism Dev Disord, 2014, 10.1007/s10803-014-2276-6.
51. Dinstein, I., et al. Unreliable evoked responses in autism. Neuron 75 (2012), 981–991.
52. Milne, E., Increased intra-participant variability in children with autistic spectrum disorders: evidence from single-trial analysis of evoked EEG. Front Psychol 2 (2011), 1–12.
53. Weinger, P.M., Zemon, V., Soorya, L., Gordon, J., Low-contrast response deficits and increased neural noise in children with autism spectrum disorder. Neuropsychologia 63 (2014), 10–18.
54. Yuen, R.K., Merico, D., Cao, H., Pellecchia, G., Alipanahi, B., Thiruvahindrapuram, B., et al. Genome-wide characteristics of de novo mutations in autism. NPJ Genom Med 1 (2016), 160271–1602710.
55. Martin, J., Cooper, M., Hamshere, M.L., Pocklington, A., Scherer, S.W., Kent, L., et al. Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder: evidence from copy number variants. J Am Acad Child Adolesc Psychiatry, 53(7), 2014 [761–70.e26].
56. Gazzellone, M.J., Zarrei, M., Burton, C.L., Walker, S., Uddin, M., Shaheen, S.M., et al. Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variation. J Neurodev Disord, 8, 18 2016, 36.
57. Strauss, K.A., Puffenberger, E.G., Huentelman, M.J., Gottlieb, S., Dobrin, S.E., Parod, J.M., et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med 354:13 (2006), 1370–1377.
58. Paemka, L., Mahajan, V.B., Ehaideb, S.N., Skeie, J.M., Tan, M.C., Wu, S., et al. Seizures are regulated by ubiquitin-specific peptidase 9 X-linked (USP9X), a de-ubiquitinase. PLoS Genet, 11(3), 2015, e1005022.
59. Paemka, L., Mahajan, V.B., Skeie, J.M., Sowers, L.P., Ehaideb, S.N., Gonzalez-Alegre, P., et al. PRICKLE1 interaction with SYNAPSIN I reveals a role in autism spectrum disorders. PLoS One, 8(12), 2013, e80737.
60. Di Gregorio, E., Riberi, E., Belligni, E.F., Biamino, E., Spielmann, M., Ala, U., et al. CNVs analysis in a cohort of isolated and syndromic DD/ID reveals novel genomic disorders, position effects and candidate disease genes. Clin Genet 92 (2017), 415–422.
61. Hughes, J.R., Melyn, M., EEG and seizures in autistic children and adolescents: further findings with therapeutic implications. Clin EEG Neurosci 36:1 (2005), 15–20.
62. Selassie, A.W., Wilson, D.A., Martz, G.U., Smith, G.G., Wagner, J.L., Wannamaker, B.B., Epilepsy beyond seizure: a population-based study of comorbidities. Epilepsy Res 108:2 (2014), 305–315.
63. Buckley, A.W., Holmes, G.L., Epilepsy and autism. Cold Spring Harb Perspect Med, 6(4), 2016, a022749.
64. Lugo, J.N., Swann, J.W., Anderson, A.E., Early-life seizures result in deficits in social behavior and learning. Exp Neurol 256 (2014), 74–80.
65. Kleen, J.K., Wu, E.X., Holmes, G.L., Scott, R.C., Lenck-Santini, P.P., Enhanced oscillatory activity in the hippocampal–prefrontal network is related to short-term memory function after early-life seizures. J Neurosci 31:43 (2011), 15397–15406.
66. Ameis, S.H., Lerch, J.P., Taylor, M.J., Lee, W., Viviano, J.D., Pipitone, J., et al. A diffusion tensor imaging study in children with ADHD, autism spectrum disorder, OCD, and matched controls: distinct and non-distinct white matter disruption and dimensional brain-behavior relationships. Am J Psychiatry 173:12 (2016), 1213–1222.
67. Ameis, S.H., Fan, J., Rockel, C., Soorya, L., Wang, A.T., Anagnostou, E., Altered cingulum bundle microstructure in autism spectrum disorder. Acta Neuropsychiatr 25:5 (2013), 275–282.
68. Ameis, S.H., Fan, J., Rockel, C., Voineskos, A.N., Lobaugh, N.J., Soorya, L., et al. Impaired structural connectivity of socio-emotional circuits in autism spectrum disorders: a diffusion tensor imaging study. PLoS One, 6(11), 2011, e28044.
69. Doyle-Thomas, K.A., Lee, W., Foster, N.E., Tryfon, A., Ouimet, T., Hyde, K.L., et al., for the NeuroDevNet ASD Imaging Group, Atypical functional brain connectivity during rest in autism spectrum disorders. Ann Neurol 77:5 (2015), 866–876.
70. Vakorin, V.A., Doesburg, S.M., Leung, R.C., Vogan, V.M., Anagnostou, E., Taylor, M.J., Developmental changes in neuromagnetic rhythms and network synchrony in autism. Ann Neurol 81:2 (2017), 199–211.
71. Forsgren, L., Nystrom, L., An incident case–referent study of epileptic seizures in adults. Epilepsy Res 6 (1990), 66–81.
72. Hesdorffer, D.C., Hauser, W.A., Ludvigsson, P., Olafsson, E., Kjartansson, O., Depression and attempted suicide as risk factors for incident unprovoked seizures and epilepsy. Ann Neurol 59 (2006), 35–41.
73. Hesdorffer, D.C., Hauser, W.A., Annegers, J.F., Cascino, G., Major depression is a risk factor for seizures in older adults. Ann Neurol 47 (2000), 246–249.
74. Kanner, A.M., Mazarati, A., Koepp, M., Biomarkers of epileptogenesis: psychiatric comorbidities (?). Neurotherapeutics 11:2 (Apr 2014), 358–372.
75. Hashimoto, K., Sawa, A., Iyo, M., Increased levels of glutamate in brains of patients with mood disorders. Biol Psychiatry 25 (2007), 1310–1316.
76. Kugaya, A., Sanacora, G., Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 10 (2005), 808–819.
77. Sanacora, G., Mason, G.F., Rothman, et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56 (1999), 1043–1047.
78. Davies, C.H., Davies, S.N., Collingridge, G.L., Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus. J Physiol 424 (1990), 513–531.
79. Evans, D.L., Charney, D., Mood disorders and medical illness: a major public health problem. Biol Psychiatry 54 (2003), 177–180.
80. Kumar, G., Couper, A., O'Brien, T.J., Salzberg, M.R., Jones, N.C., Rees, S.M., et al. The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors. Psychoneuroendocrinology 32 (2007), 834–842.
81. Kumar, G., Jones, N.C., Morris, M.J., Rees, S., O'Brien, T.J., Salzberg, M.R., Early life stress enhancement of limbic epileptogenesis in adult rats: mechanistic insights. PLoS One, 6, 2011, e24033.
82. Rajkowska, G., Miguel-Hidalgo, J.J., Wei, J., Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45 (1999), 1085–1098.
83. Sheline, Y.I., Gado, M.H., Kraemer, H.C., Untreated depression and hippocampal volume loss. Am J Psychiatry 160 (2003), 1516–1518.
84. Cotter, D.R., Pariante, C.M., Everall, I.P., Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 55 (2001), 585–595.
85. Cotter, D., Mackay, D., Chana, G., Beasley, C., Landau, S., Everall, I.P., Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 12 (2002), 386–394.
86. Salgado, P.C., Yasuda, C.L., Cendes, F., Neuroimaging changes in mesial temporal lobe epilepsy are magnified in the presence of depression. Epilepsy Behav 19 (2010), 422–427.
87. Mazarati, A.M., Pineda, E., Shin, D., Tio, D., Taylor, A.N., Sankar, R., Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta. Neurobiol Dis 37 (2010), 461–467.
88. Dunn, A.J., Swiergiel, A.H., Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Behav 81 (2005), 688–693.
89. Brambilla, D., Franciosi, S., Opp, M.R., Imeri, L., Interleukin-1 inhibits firing of serotonergic neurons in the dorsal raphe nucleus and enhances GABAergic inhibitory post-synaptic potentials. Eur J Neurosci 26 (2007), 1862–1869.
90. Vezzani, A., Balosso, S., Ravizza, T., The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22 (2008), 797–803.
91. Vezzani, A., Moneta, D., Conti, M., et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 97 (2000), 11534–11539.
92. Crespel, A., Coubes, P., Rousset, M.C., et al. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res 952 (2002), 159–169.
93. Boer, K., Jansen, F., Nellist, M., et al. Inflammatory processes in cortical tubers, and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 78 (2008), 7–21.
94. Ravizza, T., Boer, K., Redeker, S., et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 24 (2006), 128–143.
95. Monroe, S.M., Simons, A.D., Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychol Bull 110:3 (1991), 406–425.
96. Blugeot, A., et al. Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci 31:36 (2011), 12889–12899.
97. Bernard, C., The diathesis-epilepsy model: how past events impact the development of epilepsy and comorbidities. Cold Spring Harb Perspect Med, 6(6), 2016.
98. Becker, C., et al. Predicting and treating stress-induced vulnerability to epilepsy and depression. Ann Neurol 78:1 (2015), 128–136.
99. Claverie, D., et al. low beta2 main peak frequency in the electroencephalogram signs vulnerability to depression. Front Neurosci, 10, 2016, 495.
100. Bouvier, E., Brouillard, F., Molet, J., Claverie, D., Cabungcal, J.H., Cresto, N. et al., Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression, 2017 http://dx.doi.org/1038/mp2016.144 [Epub ahead of print].
101. Giacobbe, P., Mayberg, H.S., Lozano, A.M., Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation. Exp Neurol 219 (2009), 44–52.
102. Lipsman, N., Sankar, T., Downar, J., Kennedy, S.H., Lozano, A.M., Giacobbe, P., Neuromodulation for treatment-refractory major depressive disorder. CMAJ 186 (2014), 33–39.
103. Milev, R.V., Giacobbe, P., Kennedy, S.H., Blumberger, D.M., Daskalakis, Z.J., Downar, J., et al., for the CANMAT Depression Work Group, Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. neurostimulation treatments. Can J Psychiatry 61 (2016), 561–575.
104. Lozano, A.M., Lipsman, N., Probing and regulating dysfunctional circuits using deep brain stimulation. Neuron 77 (2013), 406–424.
105. Kennedy, S.H., Giacobbe, P., Rizvi, S.J., Placenza, F.M., Nishikawa, Y., Mayberg, H.S., et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 168 (2011), 502–510.
106. Sun, Y., Giacobbe, P., Tang, C.W., Barr, M.S., Rajji, T., Kennedy, S.H., et al. Deep brain stimulation modulates gamma oscillations and theta-gamma coupling in treatment resistant depression. Brain Stimul 8 (2015), 1033–1042.
107. Bergey, G.K., Morrell, M.J., Mizrahi, E.M., Goldman, A., King-Stephens, D., Nair, D., et al. Long-term treatment with responsive brain stimulation in adults with refractory partial seizures. Neurology 84 (2015), 810–817.